De Jong et al. investigated the number of tumor-infiltrating CD8+ and FoxP3+ T-lymphocytes in 368 endometrial cancers by immunohistochemistry, and indicated that a high CD8+/FOXP3+ ratio was significantly associated with a better disease-free survival [50]. This evidence concerns the gene CD8A and endometrial cancer.